Why Brainchip, Calix, Fortescue, and ResMed shares are sinking

These ASX shares sinking on Friday…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is having a difficult day and is on course to end the week in a disappointing fashion. In afternoon trade, the benchmark index is down 0.9% to 6,785.6 points.

Four ASX shares that are falling more than most today are listed below. Here's why they are dropping:

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.

Image source: Getty Images

Brainchip Holdings Ltd (ASX: BRN)

The Brainchip share price is down 20% to 68 cents following the release of a dismal third quarter update. The struggling semiconductor company, which was valued at $1.5 billion prior to today, reported cash receipts of just $118,000 for the three months. Based on this quarterly performance, investors appear concerned that this meme stock could have developed a product that nobody wants.

Calix Ltd (ASX: CXL)

The Calix share price is down 18% to $4.50. This morning this environment technology company revealed that the Australian government has withdrawn previously announced grant funding. A total of $41 million earmarked for projects has been cancelled by the government.

Fortescue Metals Group Limited (ASX: FMG)

The Fortescue share price is down 8% to $14.75. Investors have been selling this mining giant's shares following a sharp pullback in the iron ore price overnight. In addition, this morning the team at Bell Potter downgraded the company's shares to a sell rating and cut its price target by ~19% to $14.09. The broker said: "We downgrade our recommendation to Sell, largely on the impact of the increased FFI investment commitment."

ResMed Inc (ASX: RMD)

The ResMed share price is down almost 6% to $33.73. This follows the release of the medical device company's first quarter update. ResMed delivered a 5% (9% constant currency) increase in revenue to US$950.3 million but flat net income of US$222.1 million (on a non-GAAP basis). While it achieved Goldman Sachs' estimates on the top line, it missed on the bottom line.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

ASX share investor sitting with a laptop on a desk, pondering something.
Share Fallers

CSL shares crash to a 9-year low. Is it time to sell off my shares?

What's next for the beaten-down ASX biotech stock?

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Beach Energy, Domino's, Origin Energy, and Pantoro Gold shares are dropping today

Why are these shares under pressure? Let's find out.

Read more »

Frustrated and shocked business woman reading bad news online from phone.
Gold

Why is this $1.5 billion ASX 200 gold stock tumbling 8% today?

Still up 31% in a year, this ASX 200 gold stock is getting hammered today. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Cochlear, Karoon Energy, Origin Energy, and WiseTech shares are falling today

These shares are starting the week in the red. Let's find out why.

Read more »

An arrow crashes through the ground as a businessman watches on.
Share Fallers

After falling 43% in a week, are Cochlear shares now a buy?

Is this drop a warning sign?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why Brainchip, Fortescue, IGO, and Life360 shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

a woman sits next to her computer screen with her head in her hands with the screens slowing graphs on downward trajectories.
52-Week Lows

Can the beaten-down CSL share price ever reach $300 again?

CSL is near decade lows. Can it ever climb back?

Read more »

An arrow crashes through the ground as a businessman watches on.
Healthcare Shares

Cochlear stock down 40%: How much has this cost ASX investors?

One day can ruin years of success...

Read more »